Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia

ClinicalTrials.gov ID: NCT05245539

Public ClinicalTrials.gov record NCT05245539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 7:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to characterize the effects of 2 oral doses (over 8 weeks total) of CVL-231 on ambulatory blood pressure and heart rate in patients with stable schizophrenia.

Study identification

NCT ID
NCT05245539
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Cerevel Therapeutics, LLC
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 23, 2022
Primary completion
Oct 18, 2022
Completion
Nov 13, 2022
Last update posted
Dec 13, 2022

2022

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Pillar Clinical Research LLC Bentonville Arkansas 72712
Woodland International Research Group LLC - ERG - PPDS Little Rock Arkansas 72211
Collaborative NeuroScience Research, LLC - Torrance - Apex - PPDS Long Beach California 90806
Innovative Clinical Research, Inc - ClinEdge - PPDS Miami Florida 33016
Uptown Research Institute LLC Chicago Illinois 60640
Pillar Clinical Research LLC Lincolnwood Illinois 60712
Hassman Research Institute - Apex - PPDS Marlton New Jersey 08053
Neuro-Behavioral Clinical Research, Inc. North Canton Ohio 44720
Community Clinical Research Austin Texas 78754
Pillar Clinical Research LLC Richardson Texas 75080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05245539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2022 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05245539 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →